Position in NKTX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$746,474
+$85,933 QoQ
Shares Held
263,773
-15.7% QoQ
Ownership
0.368%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#33
of 136 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in NKTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $16,717,847,277 across 523 Biotechnology names. NKTX ranks #260 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
42,931,597 | $2,407,174,637 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,242,139 | $1,610,467,694 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
42,592,905 | $1,507,362,901 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,397,712 | $871,529,332 | |
| 5 | MRNA |
Moderna, Inc.
|
9,538,094 | $667,952,718 | |
| 6 | ARGX |
Argenx SE
|
643,123 | $596,670,219 | |
| 7 | TECH |
BIO-TECHNE Corp
|
6,374,717 | $450,373,747 | |
| 8 | INCY |
Incyte Corp
|
2,948,364 | $334,226,536 |
All Filings in NKTX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $746,474 | 263,773 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $660,541 | 313,054 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $575,562 | 311,116 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $979,556 | 473,217 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $537,214 | 323,625 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $860,161 | 467,481 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $4,368,314 | 1,754,344 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $1,692,268 | 374,396 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $1,784,218 | 301,899 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $1,919,797 | 177,595 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $1,419,083 | 215,013 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $305,677 | 219,914 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $505,247 | 230,708 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $608,976 | 171,544 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $639,817 | 106,815 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,961,521 | 149,052 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $4,994,659 | 405,411 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $6,749,385 | 593,092 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $11,875,800 | 773,668 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $3,370,819 | 121,209 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $5,011,010 | 158,126 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $3,150,173 | 95,750 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $1,172,047 | 19,067 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $168,245 | 5,597 | Shares | Defined | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||